echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Coatings News > Pigment and Filler News > Profit of nearly 3 billion!

    Profit of nearly 3 billion!

    • Last Update: 2021-06-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Lomon Baili (or "the company") released its 2021 semi-annual performance forecast.


    Regarding the performance increase, Lomon Baili said that during the reporting period, the company’s main product titanium dioxide market was in a strong business cycle, and the sales price increased significantly year-on-year.


    At the same time, the company has strengthened internal management, grouped and unified management in procurement, sales, finance, etc.


    Prior to this, Lomon Baili had announced that it planned to issue overseas listed foreign shares (H shares) for an initial public offering and apply for listing on the main board of the Hong Kong Stock Exchange


    Lomon Baililian Group Co.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.